EF
ATRC icon

Empowered Funds’s AtriCure ATRC Stock Holding History

Empowered Funds’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-36,574
Closed -$1.46M – 168
2020
Q3 		$1.46M Buy
+36,574
New +$1.55M 0.46% 75

Other funds holding ATRC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Empowered Funds's ATRC Position: Q4 2020 in Review

Empowered Funds sold out of AtriCure (ATRC) in Q4 2020, closing a stake of 36,574 shares — an estimated $1.46M sold.

Empowered Funds first reported a position in ATRC in Q3 2020 and held it in 1 quarter. The position peaked at $1.46M in Q3 2020. 198 funds tracked by Wall St. Rank hold ATRC as of Q4 2020.

  • Empowered Funds reported no remaining AtriCure position as of Q4 2020 after selling out during the quarter.
  • Empowered Funds sold 36,574 AtriCure shares in Q4 2020, an estimated $1.46M.
  • Empowered Funds first reported a position in AtriCure in Q3 2020 and held it in 1 quarter.
  • Empowered Funds's AtriCure position peaked at $1.46M in Q3 2020.
  • 198 funds tracked by Wall St. Rank held AtriCure as of Q4 2020.

Based on Empowered Funds's 13F filing for Q4 2020, filed 2 Feb 2021.